BNP Paribas Financial Markets’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-372
| Closed | -$3.57K | – | 3900 |
|
|
2019
Q2 | $3.57K | Sell |
372
-231
| -38% | -$2.22K | ﹤0.01% | 3651 |
|
|
2019
Q1 | $16.2K | Buy |
603
+461
| +325% | +$12.4K | ﹤0.01% | 3360 |
|
|
2018
Q4 | $3.21K | Buy |
142
+49
| +53% | +$1.11K | ﹤0.01% | 3040 |
|
|
2018
Q3 | $5.13K | Hold |
93
| – | – | ﹤0.01% | 3381 |
|
|
2018
Q2 | $6.64K | Sell |
93
-478
| -84% | -$34.1K | ﹤0.01% | 3313 |
|
|
2018
Q1 | $35.1K | Buy |
571
+22
| +4% | +$1.35K | ﹤0.01% | 3147 |
|
|
2017
Q4 | $69.2K | Buy |
549
+374
| +214% | +$47.2K | ﹤0.01% | 2835 |
|
|
2017
Q3 | $23.9K | Sell |
175
-12
| -6% | -$1.64K | ﹤0.01% | 3000 |
|
|
2017
Q2 | $26.7K | Buy |
187
+182
| +3,640% | +$26K | ﹤0.01% | 2987 |
|
|
2017
Q1 | $827 | Sell |
5
-16
| -76% | -$2.65K | ﹤0.01% | 3157 |
|
|
2016
Q4 | $1.71K | Sell |
21
-102
| -83% | -$8.28K | ﹤0.01% | 3300 |
|
|
2016
Q3 | $9.4K | Buy |
123
+52
| +73% | +$3.97K | ﹤0.01% | 3189 |
|
|
2016
Q2 | $6.11K | Buy |
+71
| New | +$6.11K | ﹤0.01% | 3171 |
|
|
2016
Q1 | – | Sell |
-359
| Closed | -$72K | – | 3281 |
|
|
2015
Q4 | $72K | Sell |
359
-19
| -5% | -$3.81K | ﹤0.01% | 2551 |
|
|
2015
Q3 | $56.4K | Buy |
378
+226
| +149% | +$33.7K | ﹤0.01% | 2772 |
|
|
2015
Q2 | $145K | Buy |
152
+121
| +390% | +$115K | ﹤0.01% | 1891 |
|
|
2015
Q1 | $22.7K | Buy |
+31
| New | +$22.7K | ﹤0.01% | 2312 |
|
|
2014
Q4 | – | Sell |
-66
| Closed | -$26.4K | – | 3070 |
|
|
2014
Q3 | $26.4K | Buy |
66
+54
| +450% | +$21.6K | ﹤0.01% | 2518 |
|
|
2014
Q2 | $3.16K | Buy |
+12
| New | +$3.16K | ﹤0.01% | 2374 |
|
|
2014
Q1 | – | Sell |
-7
| Closed | -$2K | – | 3367 |
|
|
2013
Q4 | $2K | Buy |
+7
| New | +$2K | ﹤0.01% | 3133 |
|